Sign in →

Test ID BLOD0356 Quad Screen (Second Trimester) Maternal, Serum

Useful For

Prenatal screening for open neural tube defect (alpha-fetoprotein only), trisomy 21 (alpha-fetoprotein, human chorionic gonadotropin, estriol, and inhibin A) and trisomy 18 (alpha-fetoprotein, human chorionic gonadotropin, and estriol)

Specimen Type

Serum


Necessary Information


In order to provide the best results, either answer the order entry questions or provide the required information using the Second Trimester Maternal Screening Alpha-Fetoprotein / Quad Screen Patient Information (T595).



Specimen Required


Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. Do not collect specimen after amniocentesis as this could affect results.

2. Centrifuge and aliquot serum into plastic vial within 2 hours of collection

Additional Information:

1. For an assessment that includes neural tube defect results, gestational age must be between 15 weeks, 0 days and 22 weeks, 6 days.

2. Assessments for trisomy 21 (Down syndrome) and trisomy 18 (Edwards syndrome) only are available between 14 weeks, 0 days and 22 weeks, 6 days.

3. Initial or repeat testing is determined in the laboratory at the time of report and will be reported accordingly. To be considered a repeat test for the patient, the testing must be within the same pregnancy and trimester, with interpretable results for the same tests, and both tests are performed at Mayo Clinic.

4. Maternal Serum Screening patient education brochure (T522) is available upon request.


Specimen Minimum Volume

0.75 mL

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus OK

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 7 days
  Frozen  90 days
  Ambient  7 days

Day(s) Performed

Monday through Friday

Report Available

4 to 6 days

Method Name

Immunoenzymatic Assay

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

81511

Secondary ID

113145

Reporting Name

QUAD SCRN (2nd Tri) Maternal, S

Reference Values

NEURAL TUBE DEFECTS:

An alpha-fetoprotein (AFP) multiple of the median (MoM) <2.5 is reported as screen negative.

AFP MoM ≥2.5 (singleton and twin pregnancies) are reported as screen positive.

 

DOWN SYNDROME:

Calculated screen risks <1/270 are reported as screen negative, risks ≥1/270 are reported as screen positive.

 

TRISOMY 18:

Calculated screen risks <1/100 are reported as screen negative, risks ≥1/100 are reported as screen positive.

 

An interpretive report will be provided.

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.
Sanford Laboratories - Fargo Additional Information:

SANFORD INTERFACE BUILD INFORMATION

Result Code Result Code Description
17111 Recalculated Maternal Serum Screen
22806 Results Summary
17138 Down Syndrome Screen Risk Estimate
17139 Down Syndrome Maternal Age Risk
17140 Trisomy 18 Screen Risk Estimate
22807 Neural Tube Defect Risk Estimate
17134 AFP
22808 AFP Mom
22809 AFP Mom (14,0-14,6)
17135 UE3
22810 UE3 Mom
17136 HCG, Total
22811 HCG, Total Mom
22812 Inhibin Mom
17137 Inhibin
17141 Interpretation
17143 Recommended Follow Up
17142 Additional Comments
17113 Birthdate
17114 Calculated Age at EDD
17115 Maternal Weight
17116 Maternal Weight
17117 Insulin Dependent Diabetes
22813 Patient Race
22814 Current Cigarette Smoking Status
17123 EDD By U/S Scan
17130 GA on Collection by U/S Scan
17125 EDD By LMP
17131 GA on Collection By Dates
17133 GA Used in Risk Estimate
17119 Number of Fetuses
22815 Number of Chorions
17120 IVF Pregnancy
22816 Prev Down (T21)/Trisomy Pregnancy
22817 Prev Pregnancy W/Neural Tube Defect
22818 Patient or Father of Baby Has a NTD
22819 Initial or Repeat Testing
22820 Physician Phone Number
17144 General Test Information